Treat U
Innovative nanotechnology platforms for precise drug delivery, bringing significant value to patients, healthcare professionals, and the healthcare system.
Innovative nanotechnology platforms for precise drug delivery, bringing significant value to patients, healthcare professionals, and the healthcare system.
Treat U is a biotechnology startup that focuses on innovative nanotechnology platforms for precise drug delivery, offering significant value to patients, healthcare professionals, and the healthcare system. Their advanced nanotechnology-based platforms are designed for precise drug delivery, including small drugs or siRNA, providing technological benefits that surpass current commercial products, particularly in Oncology. Their market approach involves out-licensing proprietary technology to Pharmaceutical companies after Phase I or Phase II clinical testing. Founded in 2010, Treat U has attracted a €760.00K Seed Round investment from Portugal Ventures in 25 July 2013. With a skilled team proficient in nanotechnology platforms, pharmacology, drug development, clinical trials, and business development, Treat U effectively meets various needs across the medicines value chain. This startup shows promising potential in revolutionizing drug delivery methods, making it an attractive prospect for investors seeking innovative solutions in the healthcare industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | €760.00K | 1 |
|
25 Jul 2013 |
No recent news or press coverage available for Treat U.
We care about your data, and we'd love to use cookies make your experience better.
